Innoviva (INVA) Acquisitions (2022)
Innoviva (INVA) reported Acquisitions of $23.1 million for Q3 2022, little changed quarter-over-quarter from $23.1 million in Q1 2022.
Innoviva (INVA) Acquisitions (2022) Analysis & Trends
Innoviva has reported Acquisitions for 1 years, with the latest figure at $23.1 million in Q3 2022.
- For the quarter ending Q3 2022, Acquisitions changed N/A year-over-year to $23.1 million; the trailing twelve-month figure through Sep 2023 stood at $23.1 million (down 50.0% YoY), and the FY2022 full-year result was $23.1 million, changed N/A from the prior year.
- Acquisitions for Q3 2022 stood at $23.1 million, roughly flat from $23.1 million in the prior quarter.
- The five-year high for Acquisitions was $23.1 million in Q1 2022, with the low at $23.1 million in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Innoviva | 1.69 Bn | 1.08 Bn | 75.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 23.07 Mn |
| Mar 31, 2022 | 23.07 Mn |